Applied Biomimetic Highlights DairySep™ Product at Membrane Technology Forum

11 June, 2019
For Public Release

Gaithersburg, MD ‐‐ Applied Biomimetic, a leader in the convergence of polymer and protein membrane technologies, is showcasing its DairySep™ high performance ultrafiltration at the Membrane Technology Forum in Minneapolis this week.

William Harvey, Applied Biomimetic Vice President, commented “We have participated in this conference ever since we launched our DairySep™ ultrafiltration elements three years ago. The engagement level with our customers in the dairy and enzyme industry is very high at this conference, and there is real interest experiencing the highest productivity ultrafiltration elements available in the industry.”

Commenting further: “Our products are in eight live production environments at some of the largest dairy facilities in Europe and North America, and this conference is a unique venue to convey our DairySep™ product value proposition and accelerating customer adoption.”

More information on the conference can be found at https://www.dairyfoods.com/membrane-forum/.

About Applied Biomimetic A/S:

Applied Biomimetic is a leader in the convergence of polymer and protein membrane technology. We have developed a high‐performance membrane platform for water, life science, enzyme, food, and dairy separation applications.

Our core technology is based on new chemistry and manufacturing methods to achieve highly permeable membrane material with narrow molecular size exclusion cut‐off. By adding an active protein layer, the membranes will separate constituents at the ion level. We specialize in block copolymer synthesis and lamellar phases self‐assembly. Applied Biomimetic holds global patents for the concept of embedding proteins in a proprietary polymeric membrane structure. We are also recognized as a leader in the expression, purification, and production scale‐up of porins from biological sources as well as synthesis of various types of polymeric amphiphiles.

We foresee a number of new innovative applications for our technology platform that may be established at a later stage, e.g. new delivery mechanisms for pharmaceuticals, new coatings for contact lenses, and more effective products for the cosmetics industry.

Applied Biomimetic American Dairy Products Institute

6 May, 2019
For Public Release

Gaithersburg, MD ‐‐ Applied Biomimetic, a leader in the convergence of polymer and protein membrane technologies, participated at the Annual Conference of the American Dairy Products Institute in Chicago this week.

William Harvey, Applied Biomimetic Vice President, remarked “This organization represents the dairy industry not just within its members, but also serves as conduit of trends of dairy product end users, regulators, and governments. The ADPI really sets the tone, values and strategy for the dairy industry.

We are proud to be a member of this organization, and look forward to helping drive change, especially in the adoption of new technologies that contribute to higher facility productivity and the development of value‐added dairy products.”

More information on the ADPI can be found at https://www.adpi.org/

About Applied Biomimetic A/S:

Applied Biomimetic is a leader in the convergence of polymer and protein membrane technology. We have developed a high‐performance membrane platform for water, life science, enzyme, food, and dairy separation applications.

Our core technology is based on new chemistry and manufacturing methods to achieve highly permeable membrane material with narrow molecular size exclusion cut‐off. By adding an active protein layer, the membranes will separate constituents at the ion level. We specialize in block copolymer synthesis and lamellar phases self‐assembly. Applied Biomimetic holds global patents for the concept of embedding proteins in a proprietary polymeric membrane structure. We are also recognized as a leader in the expression, purification, and production scale‐up of porins from biological sources as well as synthesis of various types of polymeric amphiphiles.

We foresee a number of new innovative applications for our technology platform that may be established at a later stage, e.g. new delivery mechanisms for pharmaceuticals, new coatings for contact lenses, and more effective products for the cosmetics industry.

Applied Biomimetic New Factory Update

18 March, 2019
For Public Release

Gaithersburg, MD ‐‐ Applied Biomimetic, a leader in the convergence of polymer and protein membrane technologies, is pleased to report on the progress at its new manufacturing facility.

CEO Steen Sondergaard Nissen, commenting on the progress: “We are nearly complete with all of the capabilities required to fulfill the element needs of our customers while achieving both state‐of‐the‐art as well as real economy of scale. We also continue to hire experienced manufacturing and operations personnel from within the membrane industry, as well as other industries to drive operations excellence. We would also like to thank the Montgomery County Economic Development Corporation (MCEDC), along with City of Gaithersburg and our contractors and suppliers that have help us achieve so much in so little time. We look forward to the grand opening of the facility in the coming months.”

About Applied Biomimetic A/S:

Applied Biomimetic is a leader in the convergence of polymer and protein membrane technology. We have developed a high‐performance membrane platform for water, life science, enzyme, food, and dairy separation applications.

Our core technology is based on new chemistry and manufacturing methods to achieve highly permeable membrane material with narrow molecular size exclusion cut‐off. By adding an active protein layer, the membranes will separate constituents at the ion level. We specialize in block copolymer synthesis and lamellar phases self‐assembly. Applied Biomimetic holds global patents for the concept of embedding proteins in a proprietary polymeric membrane structure. We are also recognized as a leader in the expression, purification, and production scale‐up of porins from biological sources as well as synthesis of various types of polymeric amphiphiles.

We foresee a number of new innovative applications for our technology platform that may be established at a later stage, e.g. new delivery mechanisms for pharmaceuticals, new coatings for contact lenses, and more effective products for the cosmetics industry.

DairySep™ Ultrafiltration Featured at the Membrane Technology Forum

Applied Biomimetic features its DairySep™ Ultrafiltration technology at the Membrane Technology Forum in Minneapolis, Minnesota on June 4th – 7th. DairySep™ elements are now in live dairy production environments at some of the largest dairy and enzyme plants in the US and Europe.

Applied Biomimetic created this technology and manufactures membranes at its new state-of-the-art Membrane Development and Life Science Research Center in Gaithersburg, Maryland USA.